Back to Search
ROBERT POTENZA, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1790705945Individual
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
096993(NY)
Research & Publications (19)
Bergamot (Citrus bergamia Risso) fruit extracts as γ-globin gene expression inducers: phytochemical and functional perspectives.
PMID 19371028·J Agric Food Chem·2009
8-other
Nonmotor symptoms in Parkinson's disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model.
PMID 18335518·J Neurosci Res·2008
7-preclinical
Adenosine A(2A) receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus.
PMID 18005343·J Neurochem·2008
7-preclinical
Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration.
PMID 17483693·J Neuropathol Exp Neurol·2007
7-preclinical
Neuroprotective effects of thymosin beta4 in experimental models of excitotoxicity.
PMID 17947590·Ann N Y Acad Sci·2007
7-preclinical
Adenosine A(2A) receptors modulate BDNF both in normal conditions and in experimental models of Huntington's disease.
PMID 18404446·Purinergic Signal·2007
8-other
Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease mice.
PMID 17720507·Neurobiol Dis·2007
7-preclinical
Efficacy and safety of a low-flow veno-venous carbon dioxide removal device: results of an experimental study in adult sheep.
PMID 17069660·Crit Care·2006
4-observational
Chronic treatment with the mGlu5R antagonist MPEP reduces the functional effects of the mGlu5R agonist CHPG in the striatum of 6-hydroxydopamine-lesioned rats: possible relevance to the effects of mGlu5R blockade in Parkinson's disease.
PMID 15880742·J Neurosci Res·2005
7-preclinical
Permissive role of adenosine A2A receptors on metabotropic glutamate receptor 5 (mGluR5)-mediated effects in the striatum.
PMID 15312183·J Neurochem·2004
4-observational
Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.
PMID 15197743·J Neurosci Res·2004
7-preclinical
Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid-induced striatal toxicity: involvement of pre- and post-synaptic mechanisms and lack of direct NMDA blocking activity.
PMID 15189351·J Neurochem·2004
7-preclinical
Modulation of glutamate release and excitotoxicity by adenosine A2A receptors.
PMID 14663014·Neurology·2003
7-preclinical
Expression of OP4 (ORL1, NOP1) receptors in vascular endothelium.
PMID 14660000·Eur J Pharmacol·2003
7-preclinical
Metabotropic glutamate receptor 5 (mGluR5)-mediated phosphoinositide hydrolysis and NMDA-potentiating effects are blunted in the striatum of aged rats: a possible additional mechanism in striatal senescence.
PMID 12786971·Eur J Neurosci·2003
7-preclinical
The expression of native and oxidized LDL receptors in brain microvessels is specifically enhanced by astrocytes-derived soluble factor(s).
PMID 12095612·FEBS Lett·2002
7-preclinical
Inhibitory effect of somatostatin on neutral amino acid transport in isolated brain microvessels.
PMID 11461970·J Neurochem·2001
7-preclinical
Age-related decline in the functional response of striatal group I mGlu receptors.
PMID 11006989·Neuroreport·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2800 BRUCKNER BLVD, SUITE 306
BRONX, NY 10465 - Phone
- (718) 597-9595
Quick Facts
- NPI
- 1790705945
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile